Veronika Weyerer

Publications by Year

Research Areas

Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers, Urinary and Genital Oncology Studies, Ferroptosis and cancer prognosis, Epigenetics and DNA Methylation

Most-Cited Works

• → An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer(2021)361 cited
• → The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer Subtypes(2019)231 cited
• → Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab(2018)102 cited
• → Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype(2018)61 cited
• → Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy(2020)58 cited
• → The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers(2021)54 cited
• → Bladder Tumor Subtype Commitment Occurs in Carcinoma In Situ Driven by Key Signaling Pathways Including ECM Remodeling(2021)47 cited
• → Dual Functional States of R406W-Desmin Assembly Complexes Cause Cardiomyopathy With Severe Intercalated Disc Derangement in Humans and in Knock-In Mice(2020)45 cited
• → Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma(2019)45 cited
• → The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia(2021)41 cited